Ambani Orgochem Ltd
Incorporated in 1985, Ambani Organics Ltd is a manufacturer, processor, importer, supplier and exporter of water based specialty chemicals & dyes
- Market Cap ₹ 80.4 Cr.
- Current Price ₹ 105
- High / Low ₹ 150 / 96.2
- Stock P/E 128
- Book Value ₹ 74.5
- Dividend Yield 0.00 %
- ROCE 7.12 %
- ROE 0.04 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 0.32% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| 52 | 65 | 79 | 73 | 87 | 125 | 132 | 136 | 193 | 223 | |
| 49 | 60 | 74 | 68 | 81 | 118 | 124 | 131 | 183 | 208 | |
| Operating Profit | 3 | 5 | 6 | 5 | 6 | 6 | 8 | 5 | 9 | 14 |
| OPM % | 6% | 7% | 7% | 7% | 7% | 5% | 6% | 3% | 5% | 6% |
| 0 | 0 | 0 | 0 | 1 | 1 | 0 | 5 | 2 | 0 | |
| Interest | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 7 | 8 | 8 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 |
| Profit before tax | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 0 | 0 | 3 |
| Tax % | 32% | 17% | 28% | 39% | 35% | 28% | 35% | -1,116% | 300% | |
| 1 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | -1 | 1 | |
| EPS in Rs | 2.10 | 4.64 | 3.41 | 2.72 | 3.35 | 3.12 | 3.08 | 4.31 | -1.11 | 1.46 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 15% |
| TTM: | 43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -58% |
| 3 Years: | -79% |
| TTM: | 118% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 11% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 0% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 7 | 8 | 13 |
| Reserves | 0 | 2 | 10 | 12 | 13 | 24 | 26 | 39 | 44 | 44 |
| 13 | 16 | 15 | 20 | 34 | 53 | 52 | 61 | 60 | 61 | |
| 22 | 26 | 31 | 26 | 25 | 29 | 54 | 68 | 97 | 87 | |
| Total Liabilities | 38 | 48 | 61 | 62 | 78 | 112 | 137 | 176 | 208 | 205 |
| 12 | 13 | 13 | 15 | 21 | 22 | 21 | 59 | 77 | 84 | |
| CWIP | 0 | 0 | 0 | 2 | 0 | 9 | 47 | 8 | 7 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 26 | 35 | 48 | 46 | 56 | 80 | 69 | 109 | 124 | 121 | |
| Total Assets | 38 | 48 | 61 | 62 | 78 | 112 | 137 | 176 | 208 | 205 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| 4 | 3 | -2 | 5 | -4 | -0 | 16 | -13 | 11 | |
| -2 | -2 | -1 | -4 | -6 | -20 | -38 | -1 | 2 | |
| -2 | -1 | 5 | -2 | 10 | 27 | 17 | 14 | -3 | |
| Net Cash Flow | -0 | 0 | 3 | -1 | 1 | 7 | -5 | 0 | 10 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 112 | 103 | 104 | 117 | 127 | 94 | 78 | 72 | 80 |
| Inventory Days | 53 | 70 | 95 | 102 | 92 | 75 | 77 | 100 | 103 |
| Days Payable | 129 | 131 | 134 | 100 | 81 | 63 | 142 | 194 | 213 |
| Cash Conversion Cycle | 35 | 42 | 65 | 118 | 138 | 105 | 13 | -22 | -29 |
| Working Capital Days | -8 | 3 | 31 | 42 | 36 | 17 | -14 | 20 | -29 |
| ROCE % | 22% | 20% | 15% | 12% | 9% | 9% | 2% | 7% |
Documents
Announcements
-
Appointment
4 December 2025 - Appointed Rajesh Vasudeo Desai (DIN 00007960) as Additional Independent Director effective 04-Dec-2025, subject to shareholder approval.
-
General Updates
18 November 2025 - H1 FY26 revenue ₹109.15 crore (+33.51%); EBITDA ₹7.92 crore (+76.77%); net profit ₹0.19 crore.
-
Outcome of Board Meeting
14 November 2025 - Board approved unaudited standalone and consolidated results for half year ended Sept 30, 2025; limited review attached.
-
Outcome of Board Meeting
14 November 2025 - Board approved unaudited standalone and consolidated results for half year ended Sep 30, 2025; limited review attached.
-
Integrated Filing- Governance
18 October 2025 - Ambani Orgochem (AMBANIORGO) exempt from Reg 27(2) corporate governance report for quarter ended Sept 30, 2025.
Product Profile:[1][2]
a) Organic Peroxides
b) Paint Driers
c) Accelerators
d) Acrylic Emulsion
e) Silver Ion Disinfectant
f) Textile Auxiliaries